Fresenius Medical Care AG 2025 SR
The report for fiscal year 2025 details Fresenius Medical Care's progress in its FME Reignite strategy, focusing on patient care, sustainable operations, and employee empowerment. Key highlights include the validation of net-zero targets by the Science Based Targets initiative (SBTi) and the rollout of high-volume hemodiafiltration (HVHDF) in the U.S. The company achieved a global patient Net Promoter Score of 73 and an employee engagement score of 66%. Environmental efforts were bolstered by virtual Power Purchase Agreements, covering 41% of global electricity consumption.
Company: Fresenius Medical Care AG
Sector: Health Care
Country: Germany
Year: 2025
Type: SR
Pages: 103
Fresenius Medical Care AG
Sustainability Statement
The report for fiscal year 2025 details Fresenius Medical Care's progress in its FME Reignite strategy, focusing on patient care, sustainable operations, and employee empowerment. Key highlights include the validation of net-zero targets by the Science Based Targets initiative (SBTi) and the rollout of high-volume hemodiafiltration (HVHDF) in the U.S. The company achieved a global patient Net Promoter Score of 73 and an employee engagement score of 66%. Environmental efforts were bolstered by virtual Power Purchase Agreements, covering 41% of global electricity consumption.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees